A Societal Perspective Cost-Utility Analysis of Rivaroxaban Compared with Enoxaparin Sodium in Patients Undergoing Total Hip or Total Knee Replacement Surgery
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1304
https://www.valueinhealthjournal.com/article/S1098-3015(13)03209-9/fulltext
Title :
A Societal Perspective Cost-Utility Analysis of Rivaroxaban Compared with Enoxaparin Sodium in Patients Undergoing Total Hip or Total Knee Replacement Surgery
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03209-9&doi=10.1016/j.jval.2013.08.1304
First page :
A530
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1152